133 related articles for article (PubMed ID: 36370340)
1. Optimal CCN4 Immunofluorescence for Tissue Microarray.
Gaudreau PO; Cousineau I; Stagg J
Methods Mol Biol; 2023; 2582():13-21. PubMed ID: 36370340
[TBL] [Abstract][Full Text] [Related]
2. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
3. Hepatic Wnt1 Inducible Signaling Pathway Protein 1 (WISP-1/CCN4) Associates with Markers of Liver Fibrosis in Severe Obesity.
Pivovarova-Ramich O; Loske J; Hornemann S; Markova M; Seebeck N; Rosenthal A; Klauschen F; Castro JP; Buschow R; Grune T; Lange V; Rudovich N; Ouwens DM
Cells; 2021 Apr; 10(5):. PubMed ID: 33946738
[TBL] [Abstract][Full Text] [Related]
4. Analysis of CCN4/WISP1 Effects on Joint Tissues Using Gain- and Loss-of-Function Approaches.
van den Bosch MHJ; Blaney Davidson EN
Methods Mol Biol; 2023; 2582():369-390. PubMed ID: 36370364
[TBL] [Abstract][Full Text] [Related]
5. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer.
Gurbuz I; Chiquet-Ehrismann R
Int J Biochem Cell Biol; 2015 May; 62():142-6. PubMed ID: 25794425
[TBL] [Abstract][Full Text] [Related]
6. WISP1 aggravates cell metastatic potential by abrogating TGF-
Song D; Wang L; Su K; Wu H; Li J
Exp Biol Med (Maywood); 2021 Jun; 246(11):1244-1252. PubMed ID: 33593111
[TBL] [Abstract][Full Text] [Related]
7. WISP1/CCN4 inhibits adipocyte differentiation through repression of PPARγ activity.
Ferrand N; Béreziat V; Moldes M; Zaoui M; Larsen AK; Sabbah M
Sci Rep; 2017 May; 7(1):1749. PubMed ID: 28496206
[TBL] [Abstract][Full Text] [Related]
8. WISP1 is a novel adipokine linked to inflammation in obesity.
Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
[TBL] [Abstract][Full Text] [Related]
9. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
Maiese K
Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
[TBL] [Abstract][Full Text] [Related]
10. CCN4/WISP1 controls cutaneous wound healing by modulating proliferation, migration and ECM expression in dermal fibroblasts via α5β1 and TNFα.
Ono M; Masaki A; Maeda A; Kilts TM; Hara ES; Komori T; Pham H; Kuboki T; Young MF
Matrix Biol; 2018 Aug; 68-69():533-546. PubMed ID: 29330021
[TBL] [Abstract][Full Text] [Related]
11. WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.
Wang S; Chong ZZ; Shang YC; Maiese K
Curr Neurovasc Res; 2012 May; 9(2):91-101. PubMed ID: 22475393
[TBL] [Abstract][Full Text] [Related]
12. WISP 1 is an important survival factor in human mesenchymal stromal cells.
Schlegelmilch K; Keller A; Zehe V; Hondke S; Schilling T; Jakob F; Klein-Hitpass L; Schütze N
Gene; 2014 Nov; 551(2):243-54. PubMed ID: 25200494
[TBL] [Abstract][Full Text] [Related]
13. CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function.
Yoshioka Y; Ono M; Maeda A; Kilts TM; Hara ES; Khattab H; Ueda J; Aoyama E; Oohashi T; Takigawa M; Young MF; Kuboki T
Bone; 2016 Feb; 83():162-170. PubMed ID: 26555637
[TBL] [Abstract][Full Text] [Related]
14. WISP1 silencing confers protection against epithelial-mesenchymal transition of renal tubular epithelial cells in rats via inactivation of the wnt/β-catenin signaling pathway in uremia.
Chen YZ; Sun DQ; Zheng Y; Zheng GK; Chen RQ; Lin M; Huang LF; Huang C; Song D; Wu BQ
J Cell Physiol; 2019 Jun; 234(6):9673-9686. PubMed ID: 30556898
[TBL] [Abstract][Full Text] [Related]
15. Identification of WISP1 as a novel oncogene in glioblastoma.
Jing D; Zhang Q; Yu H; Zhao Y; Shen L
Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
[TBL] [Abstract][Full Text] [Related]
16. WISP1 genetic variants as predictors of tumor development with urothelial cell carcinoma.
Lee HL; Chiou HL; Wang SS; Hung SC; Chou MC; Yang SF; Hsieh MJ; Chou YE
Urol Oncol; 2018 Apr; 36(4):160.e15-160.e21. PubMed ID: 29277583
[TBL] [Abstract][Full Text] [Related]
17. WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone.
Ono M; Inkson CA; Sonn R; Kilts TM; de Castro LF; Maeda A; Fisher LW; Robey PG; Berendsen AD; Li L; McCartney-Francis N; Brown AC; Crawford NP; Molinolo A; Jain A; Fedarko NS; Young MF
PLoS One; 2013; 8(8):e71709. PubMed ID: 23977121
[TBL] [Abstract][Full Text] [Related]
18. The tumor cell-secreted matricellular protein WISP1 drives pro-metastatic collagen linearization.
Jia H; Janjanam J; Wu SC; Wang R; Pano G; Celestine M; Martinot O; Breeze-Jones H; Clayton G; Garcin C; Shirinifard A; Zaske AM; Finkelstein D; Labelle M
EMBO J; 2019 Aug; 38(16):e101302. PubMed ID: 31294477
[TBL] [Abstract][Full Text] [Related]
19. Expression and physiological role of CCN4/Wnt-induced secreted protein 1 mRNA splicing variants in chondrocytes.
Yanagita T; Kubota S; Kawaki H; Kawata K; Kondo S; Takano-Yamamoto T; Tanaka S; Takigawa M
FEBS J; 2007 Apr; 274(7):1655-65. PubMed ID: 17381509
[TBL] [Abstract][Full Text] [Related]
20. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors.
Gaudreau PO; Clairefond S; Class CA; Boulay PL; Chrobak P; Allard B; Azzi F; Pommey S; Do KA; Saad F; Trudel D; Young M; Stagg J
Oncoimmunology; 2019; 8(5):e1581545. PubMed ID: 31069142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
